Speaking of GILD, why is it not on your favored list? As you may recall from our previous discussions, it has returned >2500% for me so far. I am looking forward to see what happens with VRUS merger.
JNJ is also a pretty good biotech these days, albeit primarily via acquisitions. But we know why that is not on your list.
Market Data 
Markets 
AI
